High-Fat Diet Changed How the Endocannabinoid System Works in the Pancreas and Fat Tissue
Mice on a high-fat diet showed dysregulated endocannabinoid enzyme expression in the pancreas and fat tissue, with increased endocannabinoid levels in the pancreas and decreased levels in subcutaneous fat.
Quick Facts
What This Study Found
Researchers fed mice standard or high-fat diets for up to 14 weeks and mapped the endocannabinoid system in their pancreatic and fat tissues.
In the pancreas, they found that CB1 receptors and endocannabinoid-producing enzymes were primarily located in alpha cells (which make glucagon), while degrading enzymes were in beta cells (which make insulin). A high-fat diet caused endocannabinoid-producing enzymes to appear in beta cells and reduced FAAH (a degrading enzyme), resulting in elevated pancreatic endocannabinoid levels.
In subcutaneous fat tissue, the opposite occurred: endocannabinoid levels decreased, with lower expression of producing enzymes and higher expression of FAAH.
Visceral fat showed no diet-induced enzyme changes. Cannabinoid receptor levels remained unchanged in all tissues regardless of diet.
This tissue-specific dysregulation suggests the endocannabinoid system's role in metabolic disease is more complex than simply being "overactive."
Key Numbers
Pancreas: endocannabinoid levels increased on high-fat diet, with enzyme redistribution to beta cells. Subcutaneous fat: endocannabinoid levels decreased. Visceral fat: no enzyme changes. Receptor levels unchanged in all tissues.
How They Did This
Mice were fed standard or high-fat diet for up to 14 weeks. Endocannabinoid system components (CB1, CB2, NAPE-PLD, DAGLalpha, FAAH, MAGL) were mapped in pancreas and adipose tissue by immunohistochemistry. Endocannabinoid levels (2-AG, anandamide) were measured by LC-MS.
Why This Research Matters
Understanding how obesity and high-fat diet alter the endocannabinoid system in metabolically active tissues is essential for developing targeted treatments. The finding that changes are tissue-specific and bidirectional complicates the simple "endocannabinoid overactivity" model of obesity.
The Bigger Picture
This study revealed that obesity-related endocannabinoid changes are tissue-specific and involve enzyme redistribution, not just overall increases. This complexity explains why blocking CB1 receptors everywhere (as rimonabant does) produces both beneficial metabolic effects and unwanted brain effects.
What This Study Doesn't Tell Us
Mouse metabolism differs from human. Only one high-fat diet composition was tested. The functional consequences of enzyme redistribution were not directly tested. Immunohistochemistry provides semi-quantitative data.
Questions This Raises
- ?Could tissue-specific endocannabinoid modulation improve metabolic outcomes without central side effects?
- ?Do similar enzyme redistributions occur in human obesity?
Trust & Context
- Key Stat:
- Pancreas: endocannabinoids up; subcutaneous fat: endocannabinoids down on high-fat diet
- Evidence Grade:
- This is a well-designed animal study with detailed tissue mapping, providing moderate evidence for tissue-specific endocannabinoid dysregulation in diet-induced obesity.
- Study Age:
- Published in 2008. Research on peripheral endocannabinoid system function in metabolic disease has continued to expand.
- Original Title:
- Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
- Published In:
- Obesity (Silver Spring, Md.), 16(3), 553-65 (2008)
- Authors:
- Starowicz, Katarzyna M, Cristino, Luigia(2), Matias, Isabel(2), Capasso, Raffaele, Racioppi, Alessandro, Izzo, Angelo A, Di Marzo, Vincenzo
- Database ID:
- RTHC-00334
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why do endocannabinoids increase in the pancreas but decrease in fat?
The body appears to respond to a high-fat diet differently in different tissues. In the pancreas, increased endocannabinoids may affect insulin release. In subcutaneous fat, decreased levels may reflect different regulatory needs. The system is not simply "overactive" everywhere.
Does this explain why cannabis users get the munchies?
Partly. Cannabis activates CB1 receptors throughout the body, including in the pancreas and fat tissue. This study shows the endocannabinoid system is already altered by diet, so the effects of added cannabinoids may depend on metabolic state.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
- why-does-weed-make-you-hungry-munchies
- why-does-weed-make-food-taste-better
Cite This Study
https://rethinkthc.com/research/RTHC-00334APA
Starowicz, Katarzyna M; Cristino, Luigia; Matias, Isabel; Capasso, Raffaele; Racioppi, Alessandro; Izzo, Angelo A; Di Marzo, Vincenzo. (2008). Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.. Obesity (Silver Spring, Md.), 16(3), 553-65. https://doi.org/10.1038/oby.2007.106
MLA
Starowicz, Katarzyna M, et al. "Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.." Obesity (Silver Spring, 2008. https://doi.org/10.1038/oby.2007.106
RethinkTHC
RethinkTHC Research Database. "Endocannabinoid dysregulation in the pancreas and adipose ti..." RTHC-00334. Retrieved from https://rethinkthc.com/research/starowicz-2008-endocannabinoid-dysregulation-in-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.